What's new?

Added 14 days ago Drug news

Alnylam announces new and enhanced framework for value-based agreements to accelerate patient and provider access to Givlaari.

Alnylam Pharmaceuticals, Inc. announces a new and enhanced framework for value-based agreements (VBAs) designed to help patients with acute hepatic...

Added 19 hours ago Drug news

Phase III studies of DAXI in glabellar lines published in JAAD.- Revance Therapeutics

Revance Therapeutics announced the publication of the pooled data from two multicenter, randomized, double-blind, placebo-controlled Phase III studies (SAKURA 1...

Added 19 hours ago Drug news

AURORA phase III trial of Luveniq meets primary endpoint in lupus nephritis.- Aurinia Pharma

Aurinia Pharmaceuticals Inc. announced positive top-line results announced positive efficacy and safety results from its pivotal AURORA Phase III trial...

Added 19 hours ago Drug news

FDA approves Cobas vivoDx MRSA diagnostic test for detection of bacterial infection.- Roche

The FDA has authorized marketing of the Cobas vivoDx MRSA diagnostic test, from Roche, based on bacterial viability and novel...

Added 19 hours ago Drug news

Positive phase III ACHIEVE I trial results for ubrogepant published in NEJM.- Allergan

Allergan plc announced that positive results from ACHIEVE I (UBR-MD-01), a robust Phase III clinical trial evaluating the efficacy, safety...